GLPwatch
Adlyxin vs Byetta
Drug comparison
Last updated 2026-05-28 15:46 UTCAdlyxin (lixisenatide) and Byetta (exenatide) are both injectable medications for type 2 diabetes, taken under the skin. Adlyxin is made by Sanofi, while Byetta is made by AstraZeneca. Both contain different active ingredients and are used to help manage blood sugar levels in adults with type 2 diabetes.
AI summary of the sources below.
| Adlyxin | Byetta | |
|---|---|---|
| Active ingredient | lixisenatide | exenatide |
| Manufacturer | sanofi | astrazeneca |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes |
| Label updated | — | 2025-09-02 |